Endogenous opioid signalling regulates spinal ependymal cell proliferation

Area of Science:

• Neuroscience
• Cell Biology
• Regenerative Medicine

Background:

• Spinal cord injuries lead to scarring, which can impede neural regeneration and functional recovery.
• While astrocytes are known scar-forming cells, ependymal cells also contribute significantly to scar tissue after injury.
• The mechanisms controlling ependymal cell proliferation post-injury are not well understood.

Purpose of the Study:

• To identify endogenous mechanisms regulating ependymal cell proliferation following spinal cord injury.
• To explore the role of kappa-opioid signaling in controlling ependymal cell behavior.
• To investigate potential therapeutic targets for modulating spinal cord scarring.

Main Methods:

• Investigated the expression of kappa-opioid receptor (OPRK1) in cerebrospinal fluid-contacting neurons (CSF-cNs).
• Identified prodynorphin (PDYN) expression in cells neighboring CSF-cNs.
• Utilized kappa-opioid antagonists and agonists to assess effects on ependymal proliferation in vitro and in vivo, including after injury models.

Main Results:

• Kappa-opioid signaling, mediated by OPRK1 in CSF-cNs, inhibits ependymal cell proliferation.
• PDYN-expressing cells release kappa-opioids that stimulate CSF-cNs, suppressing ependymal proliferation.
• Systemic kappa-antagonist administration increased ependymal proliferation, while a kappa-agonist reduced proliferation and scar formation post-injury, improving motor function.

Conclusions:

• An endogenous kappa-opioid signaling pathway involving CSF-cNs and PDYN-expressing cells regulates ependymal proliferation.
• This pathway represents a novel mechanism for controlling scar formation after spinal cord injury.
• Targeting this pathway offers a potential pharmacological strategy to enhance neural regeneration and functional recovery.